NMTC
NASDAQNeuroOne Medical Technologies Corporation
SectorHealth CareIndustryMedical/Dental Instruments
Price$3.46-0.04 (-1.14%)
02:15 PM07:45 PM
News · 26 weeks41-40%
2025-12-142026-06-07
Mix1990d
- Insider9(47%)
- SEC Filings7(37%)
- Other3(16%)
Latest news
25 items- SECSEC Form SD filed by NeuroOne Medical Technologies CorporationSD - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Filer)
- SECSEC Form SD filed by NeuroOne Medical Technologies CorporationSD - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Filer)
- SECNeuroOne Medical Technologies Corporation filed SEC Form 8-K: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review, Regulation FD Disclosure, Financial Statements and Exhibits8-K - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Filer)
- SECSEC Form 10-Q filed by NeuroOne Medical Technologies Corporation10-Q - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Filer)
- SECNeuroOne Medical Technologies Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Filer)
- SECNeuroOne Medical Technologies Corporation filed SEC Form 8-K: Other Events8-K - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Filer)
- SECNeuroOne Medical Technologies Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Filer)
- SECSEC Form SCHEDULE 13G filed by NeuroOne Medical Technologies CorporationSCHEDULE 13G - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Subject)
- SECNeuroOne Medical Technologies Corporation filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits8-K - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Filer)
- INSIDERSEC Form 4 filed by Mills Jason Richard4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
- INSIDERSEC Form 4 filed by Mathiesen Jeffrey S4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
- INSIDERSEC Form 4 filed by Buckman Paul4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
- INSIDERSEC Form 4 filed by Andrle Edward4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
- SECNeuroOne Medical Technologies Corporation filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Filer)
- INSIDERSEC Form 4 filed by Christianson Mark4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
- INSIDERSEC Form 4 filed by Mertens Steve4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
- INSIDERSEC Form 4 filed by Rosa David A4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
- INSIDERBusiness Development Director Christianson Mark sold $734 worth of shares (917 units at $0.80), decreasing direct ownership by 0.43% to 214,283 units (SEC Form 4)4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
- INSIDERBusiness Development Director Christianson Mark sold $10,976 worth of shares (13,720 units at $0.80), decreasing direct ownership by 6% to 215,200 units (SEC Form 4)4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
- SECSEC Form DEF 14A filed by NeuroOne Medical Technologies CorporationDEF 14A - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Filer)
- PRNext-Generation Platforms Scale Across Energy, Wellness, and Smokeless Consumer SegmentsIssued on behalf of Doseology Sciences Inc.Equity-Insider.com VANCOUVER, BC, March 5, 2026 /CNW/ -- Consumers are voting with their wallets, and zero-sugar is winning. Zero-sugar beverages are driving 6x more dollar growth than regular varieties as buyers actively choose clean-label products with natural sweeteners and functional ingredients[1]. The global market is forecast to expand from $350 billion in 2024 toward $500 billion by 2029, fueled by health-conscious consumers who want naturally functional products without heavy processing[1]. This structural shift is creating validated demand for precision-dosed, portable formats across energy and wellness categories, positioning Doseology Sc
- INSIDERChief Business Officer Wambeke David J. bought $670,400 worth of shares (1,000,000 units at $0.67) (SEC Form 4)4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
- INSIDERSEC Form 3 filed by new insider Wambeke David J.3 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
- SECSEC Form PRE 14A filed by NeuroOne Medical Technologies CorporationPRE 14A - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Filer)
- SECNeuroOne Medical Technologies Corporation filed SEC Form 8-K: Other Events8-K - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Filer)
NMTC FAQ
6 questionsWhat does NeuroOne Medical Technologies Corporation do?
NeuroOne Medical Technologies Corporation operates as a medical technology company. It focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and other related brain related disorders. NeuroOne Medical Technologies Corporation has a strategic partnership with RBC Medical Innovations to develop and manufacture a...Where does NMTC stock trade?
NeuroOne Medical Technologies Corporation (NMTC) is listed on NASDAQ.What sector and industry is NMTC in?
NeuroOne Medical Technologies Corporation operates in the Health Care sector, Medical/Dental Instruments industry.What are analysts saying about NMTC?
NeuroOne Medical Technologies Corporation has had 4 recent analyst actions on file. The most recent action was from Ladenburg Thalmann: Buy with a $145.00 price target on 2025-05-05. Recent price targets range from $145.00 to $600.00.What companies are similar to NMTC?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), MDLN (Medline Inc.), BDX (Becton Dickinson and Company). Compare NMTC side-by-side with any of them on Quantisnow.How can I track NMTC on Quantisnow?
Quantisnow aggregates NeuroOne Medical Technologies Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow NMTC to receive live email and push alerts on every new disclosure.